Automated Microbiology Market
Segments - by Technology (DNA Sequencing, DNA & RNA Probe Technology [Labelling Techniques and Amplification Methods], Detection Techniques [Radioactive Methods and Non-isotopic Methods], Immunoassays, and Monoclonal Antibodies), End-users (Biotechnology Industries, Clinical Laboratories, Hospitals, and Blood Banks), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021–2028
The global automated microbiology market size is projected to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed growing prevalence of pathogen influenced diseases.
Automated microbiology is a technique used in the field of microbiology that deals with the methods for arriving more accurate and quicker delivery of disease diagnostic results. The introduction of automation in microbiology is widely considered to be a major step in the medical research projects as it enhances the productivity, efficiency, and reliability in molecular testing. It offers a primary design that helps in the identification pathogens and early detection of several infectious agents including viroid, fungus, parasite, prion, bacterium, and virus. These agents are responsible for several severe diseases such as Ebola, chickenpox, rubella, mumps, influenza, smallpox, and measles. The outbreak of new diseases has resulted in adapting and mutating bacteria, thus contributing to the importance of automated microbiology. Additionally, the rapid identification of diseases and causative pathogens is a necessary means to ensure good public health.
Over the years, there has been significant advancement in the field of microbiology. For instance, the STEC test by BioControl Systems helps to detect non-O157 serotype of e.coli with the help of molecular and food microbiology technology as well as BacT/ALERT 3D microbial detection system introduced by bioMeriux. Automated microbiology provides several benefits such as early detection and easy access system. The development of new systems provides amplified profits to service vendors and leading companies in the automated microbiology market. For instance, in April 2017, a major company offering in-vitro diagnostics solutions, bioMérieux announced that it received the approval for its innovative, fully automated blood culture system from the US Food and Drug Administration (FDA).
Market Drivers, Restraints, Trends, and Opportunities
- Rapid advancement in laboratory testing technology in microbiology-based research is expected to spur the growth of automated microbiology market.
- Rising cases of several infectious diseases and chronic illness across the globe are projected to drive the market growth during the forecast period.
- Increasing demand for better quality laboratory services, rising need for timely results, and wide workforce in laboratory testing are expected to boost the market growth during the forecast period.
- High price and large footprints of these systems along with the lack of skilled professionals to handle these systems are projected to hamper the market growth.
- Introduction of innovative technologies such as mass spectrometry, liquid transport media, molecular techniques, and automated identification & susceptibility systems is anticipated to boost the standardization of this technology, thereby ensuring the market growth.
Scope of the Report
The report on the global automated microbiology market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Automated Microbiology Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Technology (DNA Sequencing, DNA & RNA Probe Technology [Labelling Techniques and Amplification Methods], Detection Techniques [Radioactive Methods and Non-isotopic Methods], Immunoassays, and Monoclonal Antibodies) and End-users (Biotechnology Industries, Clinical Laboratories, Hospitals, and Blood Banks) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMeriux, Inc., QIAGEN GmbH, Beckman Coulter, Agilent Technologies, Inc., Gene-Probe, Inc., Affymetrix, Inc., and Abbott Laboratories. |
Market Segment Insights
Monoclonal antibodies segment is projected to account for a significant market share
On the basis of technology, the market is segmented into DNA sequencing, DNA & RNA probe technology, detection techniques, immunoassays, and monoclonal antibodies. The DNA & RNA probe technology segment is further segmented into labelling techniques and amplification methods while the detection techniques segment is classified as radioactive methods and non-isotopic methods. The monoclonal antibodies segment is projected to account for a significant market share during the forecast period. The monoclonal antibodies are extensively used in the development of clone of the parent cell, which is further used to detect infected cell or disease. This factor is projected to drive the segment growth. On the other hand, the DNA & RNA probe technology segment owing to rising demand for gene sequencing solutions to tackle deficiency in the treatment and diagnosis of several diseases.
Clinical laboratories segment is expected to represent a large market share
Based on end-users, the market is divided into biotechnology industries, clinical laboratories, hospitals, and blood banks. The clinical laboratories segment is expected to represent a large market share during the forecast period. A large number of microbiology researches are conducted at laboratories to detect various infectious agents. This is projected to drive the segment growth during the forecast period.
North America is anticipated to constitute a considerable market share
In terms of regions, the market is classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to constitute a considerable market share owing to early adoption of new and innovative technology in the field of medical research and increasing investment to develop advanced technology among key players in the region. The introduction of advanced in molecular diagnostic tests such as genetic probe is further boosting the regional growth of the market.
On the other hand, the market in Asia Pacific region is projected to register an impressive CAGR during the forecast period due to the gradual improvement in the healthcare infrastructure in the region. Additionally, the increasing demand for advanced technology products due to rising number of infectious and chronic disease cases in this region is further fueling the regional market growth.
Segments
Segment Covered in the ReportThe global automated microbiology market has been segmented on the basis of
Technology
- DNA Sequencing
- DNA & RNA Probe Technology
- Labelling Techniques
- Amplification Methods
- Detection Techniques
- Radioactive Methods
- Non-isotopic Methods
- Immunoassays
- Monoclonal Antibodies
- Biotechnology Industries
- Clinical Laboratories
- Hospitals
- Blood Banks
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Becton Dickinson Company
- Bio-Rad Laboratories, Inc.
- bioMeriux, Inc.
- QIAGEN GmbH
- Beckman Coulter
- Agilent Technologies, Inc.
- Gene-Probe, Inc.
- Affymetrix, Inc.
- Abbot Laboratories
Competitive Landscape
Some of the key players in the global automated microbiology market are Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMeriux, Inc., QIAGEN GmbH, Beckman Coulter, Agilent Technologies, Inc., Gene-Probe, Inc., Affymetrix, Inc., and Abbott Laboratories.
Several major players are focusing on adoption of several business strategies to expand their existing consumer base. New product launches, innovation in the existing system, collaboration, mergers & acquisitions are some of the key strategies adopted by the players.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Automated Microbiology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Automated Microbiology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Automated Microbiology Market - Supply Chain
4.5. Global Automated Microbiology Market Forecast
4.5.1. Automated Microbiology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Automated Microbiology Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Automated Microbiology Market Absolute $ Opportunity
5. Global Automated Microbiology Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Automated Microbiology Market Size and Volume Forecast by Types
5.3.1. DNA Sequencing
5.3.2. DNA & RNA Probe Technology
5.3.3. Detection Techniques
5.3.4. Immunoassays
5.3.5. Monoclonal Antibodies
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Automated Microbiology Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Automated Microbiology Market Size and Volume Forecast by End Users
6.3.1. Biotechnology Industries
6.3.2. Clinical Laboratories
6.3.3. Hospitals
6.3.4. Blood Banks
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Automated Microbiology Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Automated Microbiology Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Automated Microbiology Demand Share Forecast, 2019-2026
8. North America Automated Microbiology Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Automated Microbiology Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Automated Microbiology Market Size and Volume Forecast by Types
8.4.1. DNA Sequencing
8.4.2. DNA & RNA Probe Technology
8.4.3. Detection Techniques
8.4.4. Immunoassays
8.4.5. Monoclonal Antibodies
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Automated Microbiology Market Size and Volume Forecast by End Users
8.7.1. Biotechnology Industries
8.7.2. Clinical Laboratories
8.7.3. Hospitals
8.7.4. Blood Banks
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Automated Microbiology Demand Share Forecast, 2019-2026
9. Latin America Automated Microbiology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Automated Microbiology Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Automated Microbiology Market Size and Volume Forecast by Types
9.4.1. DNA Sequencing
9.4.2. DNA & RNA Probe Technology
9.4.3. Detection Techniques
9.4.4. Immunoassays
9.4.5. Monoclonal Antibodies
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Automated Microbiology Market Size and Volume Forecast by End Users
9.7.1. Biotechnology Industries
9.7.2. Clinical Laboratories
9.7.3. Hospitals
9.7.4. Blood Banks
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Automated Microbiology Demand Share Forecast, 2019-2026
10. Europe Automated Microbiology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Automated Microbiology Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Automated Microbiology Market Size and Volume Forecast by Types
10.4.1. DNA Sequencing
10.4.2. DNA & RNA Probe Technology
10.4.3. Detection Techniques
10.4.4. Immunoassays
10.4.5. Monoclonal Antibodies
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Automated Microbiology Market Size and Volume Forecast by End Users
10.7.1. Biotechnology Industries
10.7.2. Clinical Laboratories
10.7.3. Hospitals
10.7.4. Blood Banks
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Automated Microbiology Demand Share Forecast, 2019-2026
11. Asia Pacific Automated Microbiology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Automated Microbiology Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Automated Microbiology Market Size and Volume Forecast by Types
11.4.1. DNA Sequencing
11.4.2. DNA & RNA Probe Technology
11.4.3. Detection Techniques
11.4.4. Immunoassays
11.4.5. Monoclonal Antibodies
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Automated Microbiology Market Size and Volume Forecast by End Users
11.7.1. Biotechnology Industries
11.7.2. Clinical Laboratories
11.7.3. Hospitals
11.7.4. Blood Banks
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Automated Microbiology Demand Share Forecast, 2019-2026
12. Middle East & Africa Automated Microbiology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Automated Microbiology Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Automated Microbiology Market Size and Volume Forecast by Types
12.4.1. DNA Sequencing
12.4.2. DNA & RNA Probe Technology
12.4.3. Detection Techniques
12.4.4. Immunoassays
12.4.5. Monoclonal Antibodies
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Automated Microbiology Market Size and Volume Forecast by End Users
12.7.1. Biotechnology Industries
12.7.2. Clinical Laboratories
12.7.3. Hospitals
12.7.4. Blood Banks
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Automated Microbiology Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Automated Microbiology Market: Market Share Analysis
13.2. Automated Microbiology Distributors and Customers
13.3. Automated Microbiology Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Becton Dickinson Company
13.4.2. Bio-Rad Laboratories, Inc.
13.4.3. bioMeriux, Inc.
13.4.4. QIAGEN GmbH
13.4.5. Beckman Coulter
13.4.6. Agilent Technologies, Inc.
13.4.7. Gene-Probe, Inc.
13.4.8. Affymetrix, Inc.<
2. Assumptions and Acronyms Used
3. Research Methodology
4. Automated Microbiology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Automated Microbiology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Automated Microbiology Market - Supply Chain
4.5. Global Automated Microbiology Market Forecast
4.5.1. Automated Microbiology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Automated Microbiology Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Automated Microbiology Market Absolute $ Opportunity
5. Global Automated Microbiology Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Automated Microbiology Market Size and Volume Forecast by Types
5.3.1. DNA Sequencing
5.3.2. DNA & RNA Probe Technology
5.3.3. Detection Techniques
5.3.4. Immunoassays
5.3.5. Monoclonal Antibodies
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Automated Microbiology Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Automated Microbiology Market Size and Volume Forecast by End Users
6.3.1. Biotechnology Industries
6.3.2. Clinical Laboratories
6.3.3. Hospitals
6.3.4. Blood Banks
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Automated Microbiology Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Automated Microbiology Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Automated Microbiology Demand Share Forecast, 2019-2026
8. North America Automated Microbiology Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Automated Microbiology Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Automated Microbiology Market Size and Volume Forecast by Types
8.4.1. DNA Sequencing
8.4.2. DNA & RNA Probe Technology
8.4.3. Detection Techniques
8.4.4. Immunoassays
8.4.5. Monoclonal Antibodies
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Automated Microbiology Market Size and Volume Forecast by End Users
8.7.1. Biotechnology Industries
8.7.2. Clinical Laboratories
8.7.3. Hospitals
8.7.4. Blood Banks
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Automated Microbiology Demand Share Forecast, 2019-2026
9. Latin America Automated Microbiology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Automated Microbiology Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Automated Microbiology Market Size and Volume Forecast by Types
9.4.1. DNA Sequencing
9.4.2. DNA & RNA Probe Technology
9.4.3. Detection Techniques
9.4.4. Immunoassays
9.4.5. Monoclonal Antibodies
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Automated Microbiology Market Size and Volume Forecast by End Users
9.7.1. Biotechnology Industries
9.7.2. Clinical Laboratories
9.7.3. Hospitals
9.7.4. Blood Banks
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Automated Microbiology Demand Share Forecast, 2019-2026
10. Europe Automated Microbiology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Automated Microbiology Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Automated Microbiology Market Size and Volume Forecast by Types
10.4.1. DNA Sequencing
10.4.2. DNA & RNA Probe Technology
10.4.3. Detection Techniques
10.4.4. Immunoassays
10.4.5. Monoclonal Antibodies
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Automated Microbiology Market Size and Volume Forecast by End Users
10.7.1. Biotechnology Industries
10.7.2. Clinical Laboratories
10.7.3. Hospitals
10.7.4. Blood Banks
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Automated Microbiology Demand Share Forecast, 2019-2026
11. Asia Pacific Automated Microbiology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Automated Microbiology Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Automated Microbiology Market Size and Volume Forecast by Types
11.4.1. DNA Sequencing
11.4.2. DNA & RNA Probe Technology
11.4.3. Detection Techniques
11.4.4. Immunoassays
11.4.5. Monoclonal Antibodies
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Automated Microbiology Market Size and Volume Forecast by End Users
11.7.1. Biotechnology Industries
11.7.2. Clinical Laboratories
11.7.3. Hospitals
11.7.4. Blood Banks
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Automated Microbiology Demand Share Forecast, 2019-2026
12. Middle East & Africa Automated Microbiology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Automated Microbiology Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Automated Microbiology Market Size and Volume Forecast by Types
12.4.1. DNA Sequencing
12.4.2. DNA & RNA Probe Technology
12.4.3. Detection Techniques
12.4.4. Immunoassays
12.4.5. Monoclonal Antibodies
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Automated Microbiology Market Size and Volume Forecast by End Users
12.7.1. Biotechnology Industries
12.7.2. Clinical Laboratories
12.7.3. Hospitals
12.7.4. Blood Banks
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Automated Microbiology Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Automated Microbiology Market: Market Share Analysis
13.2. Automated Microbiology Distributors and Customers
13.3. Automated Microbiology Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Becton Dickinson Company
13.4.2. Bio-Rad Laboratories, Inc.
13.4.3. bioMeriux, Inc.
13.4.4. QIAGEN GmbH
13.4.5. Beckman Coulter
13.4.6. Agilent Technologies, Inc.
13.4.7. Gene-Probe, Inc.
13.4.8. Affymetrix, Inc.<
Our Clients
Related Reports
Some other reports from this category!
